Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Why do not all living kidney donor candidates proceed to donation?

Cash E, Graver A, Kuo S, Kirkland G, Hughes P, Robertson A, Jose MD.

Intern Med J. 2019 Mar;49(3):384-387. doi: 10.1111/imj.14223.

PMID:
30897662
2.

Variation in Documenting Diagnosable Chronic Kidney Disease in General Medical Practice: Implications for Quality Improvement and Research.

Kitsos A, Peterson GM, Jose MD, Khanam MA, Castelino RL, Radford JC.

J Prim Care Community Health. 2019 Jan-Dec;10:2150132719833298. doi: 10.1177/2150132719833298.

3.

Use of patient-reported outcome measures and patient-reported experience measures in renal units in Australia and New Zealand: A cross-sectional survey study.

Morton RL, Lioufas N, Dansie K, Palmer SC, Jose MD, Raj R, Salmon A, Sypek M, Tong A, Ludlow M, Boudville N, McDonald S.

Nephrology (Carlton). 2019 Mar 5. doi: 10.1111/nep.13577. [Epub ahead of print]

PMID:
30838732
4.

Adherence assessment practices in haemodialysis settings: A qualitative exploration of nurses and pharmacists' perspectives.

Ghimire S, Lee K, Jose MD, Castelino RL, Zaidi STR.

J Clin Nurs. 2019 Jun;28(11-12):2197-2205. doi: 10.1111/jocn.14821. Epub 2019 Mar 12.

PMID:
30786082
5.

The effect of hospitalization on potentially inappropriate medication use in older adults with chronic kidney disease.

Tesfaye WH, Wimmer BC, Peterson GM, Castelino RL, Jose MD, McKercher C, Zaidi STR.

Curr Med Res Opin. 2019 Jun;35(6):1119-1126. doi: 10.1080/03007995.2018.1560193. Epub 2019 Jan 11.

PMID:
30557066
6.

Infectious complications in the Southern Tasmanian kidney transplant population.

Abeysekera N, Graver A, Cooley L, Kirkland G, Jose MD.

Nephrology (Carlton). 2018 Aug 27. doi: 10.1111/nep.13482. [Epub ahead of print]

PMID:
30152077
7.

Medication adherence assessment practices in dialysis settings: A survey of renal nurses' perceptions.

Ghimire S, Banks C, Jose MD, Castelino RL, Zaidi STR.

J Clin Nurs. 2019 Feb;28(3-4):528-537. doi: 10.1111/jocn.14642. Epub 2018 Aug 28.

PMID:
30091498
8.

Medication Regimen Complexity and Hospital Readmission in Older Adults With Chronic Kidney Disease.

Tesfaye WH, Peterson GM, Castelino RL, McKercher C, Jose MD, Wimmer BC, Zaidi STR.

Ann Pharmacother. 2019 Jan;53(1):28-34. doi: 10.1177/1060028018793419. Epub 2018 Aug 2.

PMID:
30070583
9.

Australian Community Pharmacists' Experience of Implementing a Chronic Kidney Disease Risk Assessment Service.

Gheewala PA, Peterson GM, Zaidi STR, Jose MD, Castelino RL.

Prev Chronic Dis. 2018 Jun 14;15:E81. doi: 10.5888/pcd15.170485.

10.

Clinical quality registries for clinician-level reporting: strengths and limitations.

Sypek MP, Jose MD, McDonald SP.

Med J Aust. 2018 Apr 16;208(7):322-323. No abstract available.

PMID:
29642821
11.

Public knowledge of chronic kidney disease evaluated using a validated questionnaire: a cross-sectional study.

Gheewala PA, Peterson GM, Zaidi STR, Jose MD, Castelino RL.

BMC Public Health. 2018 Mar 20;18(1):371. doi: 10.1186/s12889-018-5301-4.

12.

Evaluation of a chronic kidney disease risk assessment service in community pharmacies.

Gheewala PA, Peterson GM, Zaidi STR, Jose MD, Castelino RL.

Nephrology (Carlton). 2019 Mar;24(3):301-307. doi: 10.1111/nep.13247.

PMID:
29493051
13.

Patient satisfaction with a chronic kidney disease risk assessment service in community pharmacies.

Gheewala PA, Peterson GM, Zaidi STR, Jose MD, Castelino RL.

Int J Clin Pharm. 2018 Apr;40(2):458-463. doi: 10.1007/s11096-018-0603-2. Epub 2018 Feb 13.

PMID:
29442280
14.

Renal pharmacists' perceptions and current practices of assessing medication adherence in dialysis patients.

Ghimire S, Banks C, Jose MD, Castelino RL, Zaidi STR.

Int J Clin Pharm. 2018 Feb;40(1):26-35. doi: 10.1007/s11096-017-0574-8. Epub 2017 Dec 6.

PMID:
29214368
15.

Identification of the Optimal Protocol for Automated Office Blood Pressure Measurement Among Patients With Treated Hypertension.

Moore MN, Schultz MG, Nelson MR, Black JA, Dwyer NB, Hoban E, Jose MD, Kosmala W, Przewlocka-Kosmala M, Zachwyc J, Otahal P, Picone DS, Roberts-Thomson P, Veloudi P, Sharman JE.

Am J Hypertens. 2018 Feb 9;31(3):299-304. doi: 10.1093/ajh/hpx180.

PMID:
29126128
16.

Practice of Peritoneal Dialysis Catheter Flushing in Australia and New Zealand: Multi-Center Cross-Sectional Survey.

Cho Y, Boudville N, Palmer SC, Chow JSF, Hawley CM, Jose MD, MacGinley R, Huang L, Moodie JA, Nguyen T, Robison L, Wong J, Johnson DW.

Perit Dial Int. 2018 Mar-Apr;38(2):98-103. doi: 10.3747/pdi.2017.00108. Epub 2017 Nov 2.

PMID:
29097486
17.

Fatal Dialysis Vascular Access Hemorrhage.

Jose MD, Marshall MR, Read G, Lioufas N, Ling J, Snelling P, Polkinghorne KR.

Am J Kidney Dis. 2017 Oct;70(4):570-575. doi: 10.1053/j.ajkd.2017.05.014. Epub 2017 Jun 30.

18.

Medication adherence perspectives in haemodialysis patients: a qualitative study.

Ghimire S, Castelino RL, Jose MD, Zaidi STR.

BMC Nephrol. 2017 May 22;18(1):167. doi: 10.1186/s12882-017-0583-9.

19.

Effectiveness of targeted screening for chronic kidney disease in the community setting: a systematic review.

Gheewala PA, Zaidi STR, Jose MD, Bereznicki L, Peterson GM, Castelino RL.

J Nephrol. 2018 Feb;31(1):27-36. doi: 10.1007/s40620-017-0375-0. Epub 2017 Feb 8. Review.

PMID:
28181150
20.

Gender differences in the dialysis treatment of Indigenous and non-Indigenous Australians.

McKercher C, Jose MD, Grace B, Clayton PA, Walter M.

Aust N Z J Public Health. 2017 Feb;41(1):15-20. doi: 10.1111/1753-6405.12621. Epub 2016 Dec 13.

PMID:
27960225
21.
22.

Stability of Cefepime in pH-Neutral Peritoneal Dialysis Solutions Packaged in Dual-Compartment Bags.

Yousaf F, Zaidi ST, Wanandy T, Jose MD, Patel RP.

Perit Dial Int. 2016 Jul-Aug;36(4):457-9. doi: 10.3747/pdi.2015.00169.

23.

A web-based training program to support chronic kidney disease screening by community pharmacists.

Gheewala PA, Peterson GM, Zaidi ST, Bereznicki L, Jose MD, Castelino RL.

Int J Clin Pharm. 2016 Oct;38(5):1080-6. doi: 10.1007/s11096-016-0330-5. Epub 2016 Jun 21.

PMID:
27329381
24.

Comparison of equations for dosing of medications in renal impairment.

Khanal A, Peterson GM, Jose MD, Castelino RL.

Nephrology (Carlton). 2017 Jun;22(6):470-477. doi: 10.1111/nep.12834.

PMID:
27278107
25.

Medication Regimen Complexity and Adherence in Haemodialysis Patients: An Exploratory Study.

Ghimire S, Peterson GM, Castelino RL, Jose MD, Zaidi ST.

Am J Nephrol. 2016;43(5):318-24. doi: 10.1159/000446450. Epub 2016 May 11.

PMID:
27166159
26.

Stability of Tigecycline in Different Types of Peritoneal Dialysis Solutions.

Robiyanto R, Zaidi ST, Shastri MD, Castelino RL, Wanandy ST, Jose MD, Patel RP.

Perit Dial Int. 2016 Jul-Aug;36(4):410-4. doi: 10.3747/pdi.2015.00170. Epub 2015 Nov 2.

27.

Chronic kidney disease in the Top End of the Northern Territory of Australia, 2002-2011: a retrospective cohort study using existing laboratory data.

Lawton PD, Cunningham J, Hadlow N, Zhao Y, Jose MD.

BMC Nephrol. 2015 Oct 22;16:168. doi: 10.1186/s12882-015-0166-6.

28.

Associations of fish oil and vitamin B and E supplementation with cardiovascular outcomes and mortality in people receiving haemodialysis: a review.

Bessell E, Jose MD, McKercher C.

BMC Nephrol. 2015 Aug 18;16:143. doi: 10.1186/s12882-015-0142-1. Review.

29.

Estimation of Surgery Capacity in Haiti: Nationwide Survey of Hospitals.

Tran TM, Saint-Fort M, Jose MD, Henrys JH, Pierre Pierre JB, Cherian MN, Gosselin RA.

World J Surg. 2015 Sep;39(9):2182-90. doi: 10.1007/s00268-015-3089-2.

PMID:
26017314
30.

Potentially inappropriate prescribing of renally cleared drugs in elderly patients in community and aged care settings.

Khanal A, Peterson GM, Castelino RL, Jose MD.

Drugs Aging. 2015 May;32(5):391-400. doi: 10.1007/s40266-015-0261-1.

PMID:
25925940
31.

Survival of Indigenous Australians receiving renal replacement therapy: closing the gap?

Lawton PD, Cunningham J, Gray NA, Chatfield MD, Baade PD, Murali K, Jose MD.

Med J Aust. 2015 Apr 6;202(6):297. No abstract available.

PMID:
25832149
32.

Survival of Indigenous Australians receiving renal replacement therapy: closing the gap?

Lawton PD, Cunningham J, Zhao Y, Gray NA, Chatfield MD, Baade PD, Murali K, Jose MD.

Med J Aust. 2015 Mar 2;202(4):200-4. Erratum in: Med J Aust. 2015 Apr 6;202(6):297.

PMID:
25716603
33.

Randomized trial investigating the safety and efficacy of influenza vaccination in patients with antineutrophil cytoplasmic antibody-associated vasculitis.

Jeffs LS, Peh CA, Jose MD, Lange K, Hurtado PR.

Nephrology (Carlton). 2015 May;20(5):343-51. doi: 10.1111/nep.12416.

PMID:
25656094
34.

Stability of ampicillin and amoxicillin in peritoneal dialysis solutions.

Patel RP, Li K, Shastri M, Wanandy T, Jose MD.

Am J Health Syst Pharm. 2015 Jan 1;72(1):13-4. doi: 10.2146/ajhp130717. No abstract available.

PMID:
25511830
35.

Dialysis outcomes of elderly Indigenous and non-Indigenous Australians.

McKercher C, Chan HW, Clayton PA, McDonald S, Jose MD.

Nephrology (Carlton). 2014 Oct;19(10):610-6. doi: 10.1111/nep.12317.

PMID:
25066470
36.

The activation mode of the mechanosensitive ion channel, MscL, by lysophosphatidylcholine differs from tension-induced gating.

Mukherjee N, Jose MD, Birkner JP, Walko M, Ingólfsson HI, Dimitrova A, Arnarez C, Marrink SJ, Koçer A.

FASEB J. 2014 Oct;28(10):4292-302. doi: 10.1096/fj.14-251579. Epub 2014 Jun 23.

37.

Renal drug dosing recommendations: evaluation of product information for brands of the same drug.

Khanal A, Peterson GM, Castelino RL, Jose MD.

Intern Med J. 2014 Jun;44(6):591-6. doi: 10.1111/imj.12446.

PMID:
24946814
38.

Studying mechanosensitive ion channels with an automated patch clamp.

Barthmes M, Jose MD, Birkner JP, Brüggemann A, Wahl-Schott C, Koçer A.

Eur Biophys J. 2014 Mar;43(2-3):97-104. doi: 10.1007/s00249-014-0944-2. Epub 2014 Feb 14.

PMID:
24526306
39.

Stability of the combination of ceftazidime and cephazolin in icodextrin or pH neutral peritoneal dialysis solution.

Patel RP, Shastri MD, Bakkari M, Wanandy T, Jose MD.

Perit Dial Int. 2014 Mar-Apr;34(2):212-8. doi: 10.3747/pdi.2013.00034. Epub 2014 Jan 2.

40.

Dose adjustment guidelines for medications in patients with renal impairment: how consistent are drug information sources?

Khanal A, Castelino RL, Peterson GM, Jose MD.

Intern Med J. 2014 Jan;44(1):77-85. doi: 10.1111/imj.12291.

PMID:
24112311
41.

Physical and chemical stability of ceftazidime and cefazolin in peritoneal dialysis solutions packaged in dual-chamber infusion bags.

Patel RP, Farawahida S, Shastri M, Wanandy T, Jose MD.

Am J Health Syst Pharm. 2013 Sep 1;70(17):1477-8. doi: 10.2146/ajhp120692. No abstract available.

PMID:
23943176
42.

Psychosocial factors in people with chronic kidney disease prior to renal replacement therapy.

McKercher C, Sanderson K, Jose MD.

Nephrology (Carlton). 2013 Sep;18(9):585-91. doi: 10.1111/nep.12138.

PMID:
23876102
43.

Psychosocial factors in adults with chronic kidney disease: characteristics of pilot participants in the Tasmanian Chronic Kidney Disease study.

McKercher CM, Venn AJ, Blizzard L, Nelson MR, Palmer AJ, Ashby MA, Scott JL, Jose MD.

BMC Nephrol. 2013 Apr 12;14:83. doi: 10.1186/1471-2369-14-83.

44.

Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: new developments and revised recommendations.

Johnson DW, Jones GR, Mathew TH, Ludlow MJ, Doogue MP, Jose MD, Langham RG, Lawton PD, McTaggart SJ, Peake MJ, Polkinghorne K, Usherwood T; Australasian Creatinine Consensus Working Group.

Med J Aust. 2012 Aug 20;197(4):224-5.

PMID:
22900871
45.

Risk factors for dialysis withdrawal: an analysis of the Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry, 1999-2008.

Chan HW, Clayton PA, McDonald SP, Agar JW, Jose MD.

Clin J Am Soc Nephrol. 2012 May;7(5):775-81. doi: 10.2215/CJN.07420711. Epub 2012 Mar 29.

46.

Plasma cell infiltrates and renal allograft outcomes in indigenous and non-indigenous people of the Northern Territory of Australia.

Rogers NM, Lawton PD, Jose MD.

Nephrology (Carlton). 2011 Nov;16(8):777-83. doi: 10.1111/j.1440-1797.2011.01487.x.

PMID:
21707840
47.

Peritoneal dialysis practice in Australia and New Zealand: a call to action.

Jose MD, Johnson DW, Mudge DW, Tranaeus A, Voss D, Walker R, Bannister KM.

Nephrology (Carlton). 2011 Jan;16(1):19-29. doi: 10.1111/j.1440-1797.2010.01390.x. Review.

PMID:
21175973
48.

Chronic kidney disease in Tasmania.

Jose MD, Otahal P, Kirkland G, Blizzard L.

Nephrology (Carlton). 2009 Dec;14(8):743-9. doi: 10.1111/j.1440-1797.2009.01198.x.

PMID:
20025683
49.

Indigenous Australians and living kidney donation.

Rogers NM, Lawton PD, Jose MD.

N Engl J Med. 2009 Oct 8;361(15):1513-6. doi: 10.1056/NEJMc0905777. No abstract available.

PMID:
19812415
50.

Functional assignment of Glu386 and Arg388 in the active site of L-galactono-gamma-lactone dehydrogenase.

Leferink NG, Jose MD, van den Berg WA, van Berkel WJ.

FEBS Lett. 2009 Oct 6;583(19):3199-203. doi: 10.1016/j.febslet.2009.09.004. Epub 2009 Sep 6.

Supplemental Content

Support Center